Please see below all current urogenital and prostate cancer clinical trials of the Central Coast Cancer Centre.
Name: SPARTAN – (Selective Prostate AR Targeting with ARN-509)
A Multicenter, Randomized, Double-Blind, Phase III Study of ARN-509 in Men with Non-Metastatic (M0) Castration-Resistant Prostate Cancer.
Protocol Number: ARN-509-003
Principal Investigator: Dr Craig Kukard
Study Coordinator: Leonie Kelly
Status: Closed
Condition: Prostate Cancer
More information about SPARTAN
Name: ENZARAD
Randomised phase 3 trial of enzalutamide in androgen deprivation therapy with radiation therapy for high risk, clinically localised, prostate cancer.
Protocol Number: ANZVP1303
Principal Investigators: Dr Andrew Kneebone, Dr Craig Kukard, Dr Steve Ruthven
Study Coordinator: Michelle Dixon
Status: Recruiting
Condition: Prostate Cancer
More information about ENZARAD
Name: PERSUS
A randomized, double-blind, placebo-controlled, multicenter Phase II trial investigating two doses of EMD 525797 in subjects with asymptomatic or mildly symptomatic metastatic castrate-resistant prostate cancer (mCRPC).
Protocol Number: EMR 62242-006
Principal Investigator: Dr Craig Kukard
Study Coordinator: Leonie Kelly
Status: Closed
Condition: Prostate cancer
More information about PERSUS
Name: CLICClinician-led improvement in cancer care (CLICC)
Testing a multifaceted implementation strategy to increase evidence-based prostate cancer care: phased randomised controlled trial
Principal Investigator: Dr Finlay Macneil
Status: Recruitment closed
Condition: Prostate Cancer
Name: NSW Prostate Cancer Registry
The establishment and ongoing management of the NSW Prostate Clinical Cancer Registry
Principal Investigator: Dr Mark Louie-Johnsun
Status: Recruiting
Condition: Prostate Cancer
More information
For more information about medical oncology clinical trials, please contact the Nurse Unit Manager on 02 4320 9890 or see:
Research and Clinical Trials
